Need for Recanalization Strategies Reinforced in P1 and P2: PCA Stroke Poor Outcomes
International Journal of Stroke (IJS) shared a reminding post on X:
”Poor outcome at 3-months is frequent in acute stroke patients with P1 and P2 occlusion.”
Read the full article here.
Flashbacks on stroke management in the ‘Predictors of poor outcome in acute stroke patients with posterior cerebral artery occlusion and medical management‘ article by Candice Sabben et al.
A kind reminder, do not miss recanalization!
In patients with acute ischemic stroke due to isolated proximal posterior cerebral artery (PCA) occlusion, poor 3-month functional outcomes remain frequent under medical management alone.
This cohort study highlights that over half of patients treated without reperfusion therapies experienced unfavorable outcomes.
Clinical and radiological predictors of poor recovery were identified, underscoring the need for optimized treatment strategies.
Greater use of intravenous thrombolysis (IVT) and future therapies focused on improving recanalization and minimizing hemorrhagic transformation warrant investigation in prospective trials.
Your daily updates on stroke management featured in Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis